Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer

Taofeek K. Owonikoko, Guojing Zhang, Xingming Deng, Michael R. Rossi, Jeffrey M. Switchenko, Gregory H. Doho, Zhengjia Chen, Sungjin Kim, Sandy Strychor, Susan M. Christner, Jan Beumer, Chunyang Li, Ping Yue, Alice Chen, Gabriel L. Sica, Suresh S. Ramalingam, Jeanne Kowalski, Fadlo R. Khuri, Shi Yong Sun

Research output: Contribution to journal › Article › peer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences